Allianz: UBS remains Neutral on the stock after CMD

(CercleFinance.com) - UBS confirms its Neutral rating on the stock and leaves its target price unchanged at E300, following the Group's CMD (investor day).


'We do not expect any significant changes in EPS/capital distribution compared to Allianz's new three-year plan', says UBS.

Allianz's credible EPS targets and growth in the retail P&C business are an integral part of the plan, but require a reassessment for a more constructive valuation. The neutral rating is reiterated," adds the research firm.

Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.